URYCVE traded at 2.38859 this Monday August 3rd, increasing 0.00324 or 0.14 percent since the previous trading session. Looking back, over the last four weeks, URYCVE gained 1.30 percent. Over the last 12 months, its price rose by 0.39 percent. Looking ahead, we forecast URYCVE to be priced at 2.38822 by the end of this quarter and at 2.40270 in one year, according to Trading Economics global macro models projections and analysts expectations.